Working with data from the Fred Hutch Cancer Center, and the Genetics and Epidemiology of Colorectal Cancer Consortium (GECCO), Pattern identified a novel drug target that is not actively expressed in any adult tissue, but is expressed in a [...]
New paper on sensing research collaboration with national labs available on medRxiv Hyperspectral sensing shown to enable agnostic reagent-free diagnostics Study addresses clear and critical need for pathogen agnostic diagnostics that can be quickly and effectively performed at point [...]
REDMOND, WA, April 3, 2024 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Mark R. Anderson, Chairman and CEO, Matt Keener, CTO, and Nidhi Singh, Ph.D., Managing Director, Product Strategy/Sales will participate in the Life Science [...]
Grant from Defense Threat Reduction Agency includes purchase of Pattern's ProSpectral research platform REDMOND, WA, November 15, 2023 -- Pattern Computer®, Inc. ("Pattern" or "the Company") today announced that Lawrence Berkeley National Laboratory (LBNL) and Los Alamos National Laboratory (LANL) [...]
Pattern Discovery Engines™ accurately detect increasing number of diseases in 3 seconds using 2 drops of saliva REDMOND, WA, APRIL 6, 2023 -- Pattern Computer®, Inc. (Pattern) is pleased to announce that Cellus Group and Pattern are collaborating to [...]
REDMOND, WA, December 8, 2021 Pattern Computer® Inc. (PCI) has improved their novel test for near real-time diagnosis of SARS-CoV-2 infections. The improved system can be calibrated to perform with 100% sensitivity (detection of positive samples), with a specificity of [...]
